How AI Can Help Heart Failure Care

A joint statement by the Heart Failure Society of America (HFSA) and the American Association of Heart Failure Nurses (AAHFN), published on January 27, 2026, emphasizes the value of integrating technology into all facets of heart failure care. The statement aims to provide clinicians with suggestions for a more team-based, forward-thinking, and actionable system of care.

Integrated health technologies (IHTs) have become extremely prominent in heart failure care of late, allowing for timely clinical intervention and facilitating care coordination between disciplines. However, widespread challenges, including suboptimal engagement from patients, digital literacy and access disparities, and poor interoperability, have stymied the uptake process. This document guides clinicians in overcoming these challenges to optimize care.1

In the final episode of a 6-part HCPLive Special Report, Adam DeVore, MD, MHS, and Laura Peters, DNP, come together to discuss the intrinsic value of including recent technological advancements in standard clinical care.

During the discussion, panelists highlighted the growing role artificial intelligence (AI) may play in helping clinicians manage this influx of information. Rather than requiring providers to manually interpret dozens—or even hundreds—of incoming data points, AI-driven platforms may soon be capable of filtering and prioritizing signals that warrant clinical attention. By identifying patterns or thresholds that indicate potential decompensation, these tools could present clinicians with concise, actionable insights rather than raw data streams, helping transform information overload into targeted clinical decision support.

Beyond supporting clinicians, AI may also serve as a bridge between patients and care teams. The panelists discussed the possibility of integrating institutional treatment protocols—such as guideline-directed medical therapy (GDMT) titration frameworks—into AI-supported systems that incorporate patient-specific metrics in real time. For example, individualized thresholds based on a patient’s weight trends, hemodynamic measurements, or other physiologic markers could trigger automated guidance. If a patient’s daily weight exceeds a personalized threshold, the system could prompt predefined actions, such as medication adjustments or clinician notification, ensuring earlier intervention while empowering patients to participate more actively in their own care.

The conversation also emphasized the expanding role of emerging technologies for patients with advanced heart failure who are not yet candidates for heart transplantation or left ventricular assist device (LVAD) therapy. For individuals in this transitional stage—where disease progression is evident but not yet severe enough for advanced mechanical support—technology-driven monitoring and intervention strategies may offer an opportunity to slow disease progression. By identifying subtle physiologic changes earlier and enabling proactive care adjustments, digital tools may help clinicians delay the need for advanced interventions, potentially improving both longevity and quality of life.

As the discussion concluded, the panelists reflected on the collaborative effort behind the statement and the importance of ongoing dialogue about how technology can be implemented thoughtfully in heart failure care. They expressed hope that the insights shared would encourage clinicians and healthcare leaders to consider how emerging tools—from AI-assisted analytics to remote monitoring platforms—might be integrated into their own institutions.

Ultimately, as heart failure care continues to evolve, thoughtful implementation of technology may help clinicians better manage complex data streams, deliver more personalized treatment, and support patients across the full continuum of disease—particularly those navigating the challenging transition toward advanced heart failure.

Our Panelists:

• Adam DeVore, MD, MHS, is an associate professor of medicine in the division of cardiology at Duke University School of Medicine, as well as the medical director of the Duke Heart Transplant program.
• Laura Peters, DNP, is an assistant professor of medicine in the advanced heart failure and cardiac transplant section within the division of cardiology at the University of Colorado, as well as a senior clinical instructor in the University of Colorado College of Nursing and the director of the Children’s Hospital Colorado and UCHealth Heart Transplant Transition Program.

Editors’ Note: Peters and DeVore report no relevant disclosures.

References

1. Cajita M, Peters L, Rao VN, et al. Integrated Health Technologies in heart failure: A scientific statement from the Heart Failure Society of America and the American Association of Heart Failure Nurses. Journal of Cardiac Failure. Published online January 27, 2026. doi:10.1016/j.cardfail.2025.08.029

2. Heart Failure Society of America. Integrated Health Technologies in Heart Failure: A Scientific Statement from the Heart Failure Society of America and American Association of Heart Failure Nurses. January 27, 2026. Accessed March 5, 2026. https://hfsa.org/integrated-health-technologies-heart-failure-scientific-statement-heart-failure-society-america-and